Abstract
Cancer survivorship care presents unique challenges in delivering quality of care. Care that is informed by evidence and guidelines and that ensures timely access according to individual need is at the core of what defines a quality approach. There has been a transformation in the concept of quality of care in survivorship from a simplistic adherence to surveillance guidelines to a much more comprehensive approach that recognizes the multidisciplinary nature of care provision across a number of settings. In this chapter, we outline the current understanding around optimal approaches to quality of survivorship care that include transitions in care, care models, supports to transition effectively, as well as consideration of the late effects of a cancer diagnosis and its treatment on survivors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Institute of Medicine. From cancer patient to cancer survivor: Lost in transition. Washington: National Academies Press; 2005. 534 p
Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2016;66(4):271–89.
Leach CR, Weaver KE, Aziz NM, et al. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv. 2015;9(2):239–51.
https://www.livestrong.org/we-can-help/healthy-living-after-treatment/your-survivorship-care-plan
Grunfeld E, Julian JA, Pond G, et al. Evaluating survivorship care plans: results of a randomized clinical trial of patients with breast cancer. J Clin Oncol. 2011;29(36):4755–62.
Salz T, Oeffinger KC, McCabe MS, et al. Survivorship care plans in research and practice. CA Cancer J Clin. 2012;62(2):101–17.
Commission on Cancer: Cancer program standards 2012: ensuring patient centred care. Chicago: American College of Surgeons; 2012. Available from: https://www.facs.org/~/media/files/quality%20programs/cancer/coc/programstandards2012.ashx
Makaryus AN, Friedman EA. Patients’ understanding of their treatment plans and diagnosis at discharge. Mayo Clin Proc. 2005;80(8):991–4.
Geiger AM, Fischberg GM, Chen W, et al. Stroke risk and tamoxifen therapy for breast cancer. J Natl Cancer Inst. 2004;96(20):1528–36.
Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow up care, surveillance protocol and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31(35):4465–70.
Survivorship guidelines. American Society of Clinical Oncology. Available from: https://www.asco.org/practice-guidelines/survivorship/survivorship-compendium.
Bast RCJ, Ravdin P, Hayes DF, et al. 2000 Update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19(6):1865–78.
Merkow R, Korenstein D, Yeahia R, et al. Quality of cancer surveillance clinical practice guidelines specificity and consistency of recommendations. JAMA Intern Med. 2017;177(5):701–9.
Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol. 2016;34(6):611–35.
Elston LJ, Simpkins J, Schultz L, et al. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005;43(6):592–9.
Stiggelbout AM, de Haes JC, Vree R, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer. 1997;75(6):914–20.
Grunfeld E, Mant D, Yudkin P, et al. Routine follow-up of breast cancer in primary care: randomised trial. BMJ. 1996;313(7058):665–9.
The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA. 1994;271(20):1587–92.
Kjeldsen BJ, Thorsen H, Whalley D, et al. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol. 1999;34(5):509–15.
Lampic C, Wennberg A, Schill JE, et al. Anxiety and cancer related worry of cancer patients at routine follow-up visits. Acta Oncol. 1994;33(2):119–25.
Loprinzi CL, Hayes D, Smith T. Doc, shouldn’t we be getting some tests? J Clin Oncol. 2000;18(11):2345–8.
Muss HB, Tell G, Case LD, et al. Perceptions of follow-up care in women with breast cancer. Am J Clin Oncol. 1991;14(1):55–9.
Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386–422.
NIH Consensus Development Panel on Ovarian Cancer. NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. JAMA. 1995;273(6):491–7.
Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol. 1992;10(6):904–11.
Grunfeld E, Levine MN, Julian JA, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24(6):848–55. Epub 2006 Jan 17
Sussman J, Varela N, Cheung M, et al. Follow up care for survivors of lymphoma who have received curative intent treatment. Curr Oncol. 2016;23(5):e499–513.
Runowicz C. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66(1):43–73.
Virgo KS, Johnson FE. Costs of surveillance after potentially curative treatment for cancer. In: Johnson FE, Virgo KS, editors. Cancer patient follow-up. St. Louis: Mosby; 1997. p. 45.
Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1987. 182 p
Renehan AG, Egger M, Saunders MP, et al. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ. 2002;324(7341):813.
Donaldson SS, Hancock SL, Hoppe RT. The Janeway lecture. Hodgkin’s disease—finding the balance between cure and late effects. Cancer J Sci Am. 1999;5(6):325–33.
Shimozuma K, Ganz PA, Petersen L, et al. Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treat. 1999;56(1):45–57.
Dales RE, Dionne G, Leech JA, et al. Preoperative prediction of pulmonary complications following thoracic surgery. Chest. 1993;104(1):155–9.
Valji AM, Maziak DE, Shamji FM, et al. Postpneumonectomy syndrome: recognition and management. Chest. 1998;114(6):1766–9.
Macmillan Cancer Support. https://www.macmillan.org.uk/information-and-support/bowel-cancer/colon/treating/surgery/bowel-function-after-surgery.html.
Arndt V, Stegmaier C, et al. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol. 2004;22(23):4829–36.
Montague D. Artificial urinary sphincter: long-term results and patient satisfaction advances in urology. Ther Adv Urol. 2012;2012:835290.
McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26(32):5220–6.
Eisbruch A. Reducing xerostomia by IMRT: what may and may not be achieved. J Clin Oncol. 2007;25(31):4863–4.
Ries LAG, Harkins D, Krapcho M. et al. SEER Cancer Statistics Review. 1975–2003, National Cancer Institute. Bethesda, MD, from: http://seer.cancer.gov/csr/1975–2003
Leisenring W, Friedman DL, Flowers ME, et al. Non melanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol. 2006;24(7):1119–26.
Sountoulides P, Koletsas N, Kikidakis D, et al. Secondary malignancies following radiotherapy for prostate cancer. Ther Adv Urol. 2010;2(3):119–25.
Bjergaard J. Radiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia. A review. Leuk Res. 1992;16(1):61–5.
Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys. 1995;33(1):179–82.
Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med. 2000;343(15):1086–94.
Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys. 2005;63(1):5–24.
Borst GR, De Jaeger K, Belderbos JS, et al. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. Int J Radiat Oncol Biol Phys. 2005;62(3):639–44.
Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol. 2004;22(15):3139–48.
Giordano SH, Kuo YF, Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97(6):419–24.
Cuzick J. Radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97(6):406–7.
Bowers DC, McNeil DE, Liu Y, et al. Stroke as a late treatment effect of Hodgkin’s disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2005;23(27):6508–15.
Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98.
Do N, Nagle D, Poylin V. Radiation proctitis: current strategies in management gastroenterology research and practice. Gastroenterol Res Pract. 2011;2011:917941.
Miller DC, Sanda MG, Dunn R, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23(12):2772–80.
Lobo RA. Potential options for preservation of fertility in women. N Engl J Med. 2005;353(1):64–73.
Wallace WH, Thomson AB, Saran F, et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738–44.
DeSantis M, Albrecht W, Holtl W, et al. Impact of cytotoxic treatment on long-term fertility in patients with germ-cell cancer. Int J Cancer. 1999;83(6):864–5.
Robinson JW, Moritz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys. 2002;54(4):1063–8.
Sherer BA, Levine LA. Current management of erectile dysfunction in prostate cancer survivors. Curr Opin Urol. 2014;24(4):401–6.
Baxter NN, Habermann EB, Tepper JE, et al. Risk of pelvic fractures in older women following pelvic irradiation. JAMA. 2005;294(20):2587–93.
Mandelblatt J, Jacobsen P, Ahles T. Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors. J Clin Oncol. 2014;32(24):2617–26.
Turner SL, Tiver KW, Boyages SC. Thyroid dysfunction following radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 1995;31(2):279–83.
Jereczek-Fossa BA, Alterio D, Jassem J, et al. Radiotherapy induced thyroid disorders. Cancer Treat Rev. 2004;30(4):369–84.
Rose SR. Cranial irradiation and central hypothyroidism. Trends Endocrinol Metab. 2001;12(3):97–104.
Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141(3):259–77.
Tannock IF, Ahles TA, Ganz PA, et al. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004;22(11):2233–9.
Wefel JS, Lenzi R, Theriault R, et al. ‘Chemobrain’ in breast carcinoma? A prologue. Cancer. 2004;101(3):466–75.
Nuver J, Smit AJ, van der Meer J, et al. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol. 2005;23(36):9130–7.
Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002;20:1578–83.
Goodwin PJ, Ennis M, Pritchard KI, et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol. 1999;17(8):2365–70.
Aisner J, Wiernik PH, Pearl P. Pregnancy outcome in patients treated for Hodgkin’s disease. J Clin Oncol. 1993;11(3):507–12.
Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12–7.
Ganz PA, Rowland JH, Desmond K, et al. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16(2):501–14.
Ganz PA, Desmond KA, Belin TR, et al. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol. 1999;17(8):2371–80.
Rowland JH, Desmond KA, Meyerowitz BE, et al. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst. 2000;92(17):1422–9.
Fallowfield L, Fleissig A, Edwards R, et al. Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. J Clin Oncol. 2001;19(7):1885–92.
Mandelblatt J, Figueiredo M, Cullen J. Outcomes and quality of life following breast cancer treatment in older women: when, why, how much, and what do women want? Health Qual Life Outcomes. 2003;1:45.
Ganz PA, Desmond KA, Leedham B, et al. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002;94:39–49.
Krupski TL, Smith MR, Le WC, et al. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer. 2004;101:541–9.
Ramaswamy B, Shapiro CL. Osteopenia and osteoporosis in women with breast cancer. Semin Oncol. 2003;30:763–75.
Macke JR, Joy AA. Skeletal health in postmenopausal survivors of early breast cancer. Int J Cancer. 2005;114:1010–5.
Hillner BE, Ingle JN, Chlebowski RT, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol. 21:4042–57.
Sleijfer S. Bleomycin-induced pneumonitis. Chest. 2001;120:617–24.
Moroso MJ, Blair RL. A review of cis-platinum ototoxicity. J Otolaryngol. 1983;12:365–9.
Ganz PA, Kwan L, Stanton AL, et al. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst. 2004;96:376–87.
Ramsey SD, Berry K, Moinpour C, Giedzinska A, Andersen MR. Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol. 2002;97:1228–34.
Kornblith AB, Ligibel J. Psychosocial and sexual functioning of survivors of breast cancer. Semin Oncol. 2003;30:799–813.
Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6:95–105.
Sprangers MA, Taal BG, Aaronson NK, te Velde A. Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum. 1995;38:361–9.
Kornblith AB, Herndon JE, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer. 2003;98:679–89.
Gore JL, Krupski T, Kwan L, Maliski S, Litwin MS. Partnership status influences quality of life in low-income, uninsured men with prostate cancer. Cancer. 2005;104(1):191–8.
Manne SL. Prostate cancer support and advocacy groups: their role for patients and family members. Semin Urol Oncol. 2002;20:45–54.
Sapp AL, Trentham-Dietz A, Newcomb PA, et al. Social networks and quality of life among female long-term colorectal cancer survivors. Cancer. 2003;98:1749–58.
Lepore SJ, Helgeson VS, Eton DT, Schulz R. Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol. 2003;22:443–52.
Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD. Functional impact of breast cancer by age at diagnosis. J Clin Oncol. 2004;22:1849–56.
Eton DT, Lepore SJ, Helgeson VS. Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors. Cancer. 2001;92:1451–9.
de Jong N, Courtens AM, Abu-Saad HH, Schouten HC. Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs. 2002;25:283–97.
Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat. 1996;38:183–99.
Wolff SN, Nichols C, Ulman D, et al. Survivorship: an unmet need of the patient with cancer—implications of a survey of the Lance Armstrong Foundation [Abstract]. Proc Am Soc Clin Oncol. 2005;23(16 suppl 6032):s6032.
Ederer F, Cutler SJ, Goldenberg IS, Eisenberg H. Causes of death among long-term survivors from breast cancer in Connecticut. J Natl Cancer Inst. 1963;30:933–47.
Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–71.
Ganz PA. A teachable moment for oncologists: cancer survivors, 10 million strong and growing! J Clin Oncol. 2005;23:5458–60.
Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21:1447–51.
Earle CC, Neville BA. Underuse of necessary care among elderly colorectal cancer survivors. Cancer. 2004;101:1712–9.
Sussman J, Bainbridge D, Evans WK. Towards integrating primary care with cancer care: a regional study of current gaps and opportunities in Canada. Healthc Policy. 2017;12(3):50–65.
American Society of Clinical Oncology. Status of the medical oncology workforce. J Clin Oncol. 1996;14:2612–21.
Halpern MT, Argenbright KE. Evaluation of effectiveness of survivorship programs: how to measure success? Lancet Oncol. 2017;18(1):e51–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Sussman, J., Grunfeld, E., Earle, C.C. (2018). Quality Care. In: Feuerstein, M., Nekhlyudov, L. (eds) Handbook of Cancer Survivorship. Springer, Cham. https://doi.org/10.1007/978-3-319-77432-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-77432-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77430-5
Online ISBN: 978-3-319-77432-9
eBook Packages: MedicineMedicine (R0)